7 research outputs found
Antitumor Activity of Auger Electron Emitter 111In Delivered by Modular Nanotransporter for Treatment of Bladder Cancer With EGFR Overexpression
Gamma-ray emitting 111In, which is extensively used for imaging, is also a source of short-range Auger electrons (AE). While exhibiting negligible effect outside cells, these AE become highly toxic near DNA within the cell nucleus. Therefore, these radionuclides can be used as a therapeutic anticancer agent if delivered precisely into the nuclei of tumor target cells. Modular nanotransporters (MNTs) designed to provide receptor-targeted delivery of short-range therapeutic cargoes into the nuclei of target cells are perspective candidates for specific intracellular delivery of AE emitters. The objective of this study was to evaluate the in vitro and in vivo efficacy of 111In attached MNTs to kill human bladder cancer cells overexpressing epidermal growth factor receptor (EGFR). The cytotoxicity of 111In delivered by the EGFR-targeted MNT (111In-MNT) was greatly enhanced on EJ-, HT-1376-, and 5637-expressing EGFR bladder cancer cell lines compared with 111In non-targeted control. In vivo microSPECT/CT imaging and antitumor efficacy studies revealed prolonged intratumoral retention of 111In-MNT with t½ = 4.1 ± 0.5 days as well as significant dose-dependent tumor growth delay (up to 90% growth inhibition) after local infusion of 111In-MNT in EJ xenograft-bearing mice
A novel bacteriochlorin–styrylnaphthalimide conjugate for simultaneous photodynamic therapy and fluorescence imaging
Propargyl-15 2 ,17 3-dimethoxy-13 1-amide of bacteriochlorin e (BChl) and a 4-(4-N,N-dimethylaminostyryl)-N-alkyl-1,8-naphthalimide bearing azide group in the N-alkyl fragment were conjugated by the copper(I)-catalyzed 1,3-dipolar cycloaddition to produce a novel dyad compound BChl–NI for anticancer photodynamic therapy (PDT) combining the modalities of a photosensitizer (PS) and a fluorescence imaging agent. A precise photo-physical investigation of the conjugate in solution using steady-state and time-resolved optical spectroscopy revealed that the presence of the naphthalimide (NI) fragment does not decrease the photosensitizing ability of the bacteriochlorin (BChl) core as compared with BChl; however, the fluorescence of naphthalimide is completely quenched due to resonance energy transfer (RET) to BChl. It has been shown that the BChl–NI conjugate penetrates into human lung adenocarcinoma A549 cells, and accumulates in the cytoplasm where it has a mixed granular-diffuse distribution. Both NI and BChl fluorescence in vitro provides registration of bright images showing perfectly intracellular distribution of BChl–NI. The ability of NI to emit light upon excitation in imaging experiments has been found to be due to hampering of RET as a result of photodestruction of the energy acceptor BChl unit. Phototoxicity studies have shown that the BChl–NI conjugate is not toxic for A549 cells at tested concentrations (o8 mM) without light-induced activation. At the same time, the concentration-dependent killing of cells is observed upon the excitation of the bacteriochlorin moiety with red light that occurs due to reactive oxygen species formation. The presented data demonstrate that the BChl–NI conjugate is a promissing dual function agent for cancer diagnostics and therapy
Synthesis and Investigation of Photophysical and Biological Properties of Novel <i>S</i>‑Containing Bacteriopurpurinimides
Novel
hybrid molecule containing 2-mercaptoethylamine was synthesized
starting from <i>O</i>-propyloxime-<i>N</i>-propoxy
bacteriopurpurinimide (dipropoxy-BPI), which was readily oxidized
in oxygen atmosphere yielding the corresponding disulfide analogue
(disulfide-BPI). Spectral, photophysical, photodynamic, and biological
properties of compound were properly evaluated. Compounds bearing
disulfide moiety can directly interact with glutathione (GSH), thereby
reducing its intracellular concentration. Indeed, mice sarcoma S37
cell line was treated in vitro with disulfide-BPI, yielding a CC<sub>50</sub> value of 0.05 ± 0.005 μM. A relatively high level
of singlet oxygen was detected. It was demonstrated (by fluorescence)
that the PS was rapidly accumulated in a cancer nest (S37) at a relatively
high level after 2 h upon intravenous administration. After 24 h,
no traces of the molecule were detected in the tumor mass. Moreover,
high photodynamic efficiency was demonstrated at doses of 150–300
J/cm<sup>2</sup> against two different in vivo tumor models, achieving
100% regression of cancer growth